Rebuttal to: Effect of heparin on TAFI-dependent inhibition of fibrinolysis

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 1, 2003, Pages 200-201

  Lisman, T ^a,b   De Groot, P G ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

BLOOD CLOTTING; BLOOD CLOTTING TEST; DOSE RESPONSE; DRUG EFFECT; FIBRINOLYSIS; HUMAN; METABOLISM; METHODOLOGY; NOTE; TIME;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; CARBOXYPEPTIDASE U; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYSIS; HEPARIN; HUMANS; TIME FACTORS;

EID: 0141818947     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00036.x     Document Type: Letter

References (8)

1. Colucci M, Pentimone A, Binetti BM, Cramarossa M, Piro D, Semeraro N. Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin. Thromb Haemost 2002; 88: 282-7.
2. von dem Borne PA, Bajzar L, Meijers JCM, Nesheim ME, Bouma BN. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. J Clin Invest 1997; 99: 2323-7.
3. Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JCM, Bouma BN. The defective downregulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration. Thromb Haemost 2001; 86: 1035-9.
4. Lisman T, Mosnier LO, Lambert T, Mauser-Bunschoten EP, Meijers JCM, Nieuwenhuis HK, de Groot PG. Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe haemophilia A. Blood 2002; 99: 175-9.
5. Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, Nieuwenhuis HK, de Groot PG. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology 2001; 121: 131-9.
6. Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Buller HR, Bouma BN. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Thromb Haemost 2000; 84: 9-14.
7. von dem Borne PA, Meijers JCM, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995; 86: 3035-42.
8. von dem Borne PA, Meijers JC, Bouma BN. Effect of heparin on the activation of factor XI by fibrin-bound thrombin. Thromb Haemost 1996; 76: 347-53.